Rise in R&D activities for advancements in hip replacement surgeries and increase in product launches & product approvals drive the growth of the global hip replacement market. PORTLAND, Ore., Aug. 11, 2022 /PRNewswire/ — Allied […]
SEngine, which spun out of Fred Hutchinson Cancer Center in 2015, plans to relocate this fall. Click here to view original post
Routinely performs aseptic cell culture of pluripotent stems cells for general maintenance or experiment execution. Medical, Dental and Vision Insurance.From… Click here to view original post
Scientists interested in working with and/or leading disease-focused research. Epidemiologists/Data scientists skilled in developing and employing statistical…From Adaptive Biotechnologies -… Click here to view original post
This position reports directly to the Head of Quality Assurance – Batch Disposition. Conduct routine lot disposition activities for finished… Click here to view original post
We are seeking a highly motivated and creative senior scientist to join the Therapeutic Discovery Research group and assist in… Click here to view original post
The Senior Scientist is responsible for developing novel chemical processes for small molecule APIs and ADC drug-linkers for each development… Click here to view original post
Scientific background plus experience in biotechnology, vaccines, and global health. The Senior Project Manager is responsible for planning, organizing, and…… Click here to view original post
Scientific background plus experience in biotechnology, vaccines, and global health. The Senior Project Manager is responsible for planning, organizing, and…… Click here to view original post
Seattle-based Omeros sold its Omidria drug franchise to Rayner Surgical Group in December in a deal projected to be worth more than $1 billion. Click here to view original post
Copyright © 2022 Biotech Networks, LLC
